InnoCare Pharma Ltd.SSE: 688428

Notice on the Review Opinions and Remarks on Publicity of Lis of Incentive Recipients List for the Initial Grant of the 2024 SSE STAR Market Restricted Stock Incentive Plan

· Issued by InnoCare Pharma Ltd. via Shanghai Stock Exchange

Filed with SSE ·

On 6ix: 6ix.com/news/notice-on-the-review-opinions-and-remarks-on-publicity-of-lis-of-incentive-recipients-list-for-the-initial-grant-of-the-2024-sse-star-market-restricted-stock-incentive-plan

Notice on the Review Opinions and Remarks on Publicity of Lis of Incentive Recipients List for the Initial Grant of the 2024 SSE STAR Market Restricted Stock Incentive Plan

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

InnoCare Pharma Ltd. on 6ix

Earlier from InnoCare Pharma

Later from InnoCare Pharma

All InnoCare Pharma news releases